__NUXT_JSONP__("/drugs/Ertumaxomab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"509077-99-0",chebiId:b,chemicalFormula:b,definition:"A murine monoclonal antibody with two antigen-recognition sites: one for CD3, an antigen expressed on mature T cells, and one for HER-2-neu, a tumor-associated antigen that promotes tumor growth.  Ertumaxomab attaches to CD3-expressing T cells and HER-2-neu-expressing tumor cells, selectively cross-linking tumor and immunologic cells which results in the recruitment of cytotoxic T cells to the T cell\u002Ftumor cell aggregate.",fdaUniiCode:"L5L45YGP1O",identifier:"C2658",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C129822","C1454"],synonyms:["Anti-CD3 x anti-HER-2-neu Bispecific Monoclonal Antibody","ERTUMAXOMAB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FErtumaxomab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Ertumaxomab","","2021-10-30T13:38:04.483Z")));